Provectus Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 8.07% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.4%	Jeffrey Morris	18,500,000	US$2.2m	0%	no data
1.58%	Eric Wachter	6,649,298	US$785.9k	0%	no data
0.75%	Edward Pershing	3,160,380	US$373.6k	0%	no data
0.64%	Bruce Horowitz	2,677,243	US$316.4k	0%	no data
0.29%	Heather Raines	1,213,153	US$143.4k	0%	no data
0.26%	Dominic Rodrigues	1,077,389	US$127.3k	0%	no data
0.048%	John Lacey	200,000	US$23.6k	0%	no data
0.035%	Gregory Bailey	145,528	US$17.2k	0%	no data
0.024%	Home Federal Bank Of Tennessee, Asset Management Arm	100,000	US$11.8k	0%	no data
0.019%	PS Foundation, Endowment Arm	81,500	US$9.6k	0%	0.48%
0.012%	Lee, Danner & Bass, Inc.	50,000	US$5.9k	0%	no data
0.0063%	Atlas Wealth LLC	26,620	US$3.1k	0%	no data
0.0048%	Academy Capital Management	20,000	US$2.4k	0%	no data
0.0048%	LBMC Investment Advisors, LLC	20,000	US$2.4k	-9.09%	no data
0.0024%	Financial Symmetry Incorporated	10,191	US$1.2k	0%	no data
0%	The Huntington Trust Company, National Association	1	US$0	0%	no data